We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Benefit-Risk Templates for Drug Reviews Lack Patient Input Process: NORD
FDA’s Benefit-Risk Templates for Drug Reviews Lack Patient Input Process: NORD
May 17, 2013
The FDA’s draft plan for implementing standard benefit-risk templates in drug reviews lacks a process for including patient concerns, the National Organization of Rare Diseases (NORD) says.